ELOVL1 blocking peptide product blog
Tags: Blocking Peptide; ELOVL1; ELOVL1 blocking peptide;
The ELOVL1 elovl1 (Catalog #MBS9222950) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The ELOVL1 elovl1 product has the following accession number(s) (GI #20137931) (NCBI Accession #Q9BW60.1) (Uniprot Accession #Q9BW60). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Condensing enzyme that catalyzes the synthesis of both saturated and monounsaturated very long chain fatty acids (VLCFAs). Exhibits activity toward saturated C18 to C26 acyl-CoA substrates, with the highest activity towards C22:0 acyl-CoA. Important for saturated C24:0 and monounsaturated C24:1 sphingolipid synthesis. Indirectly inhibits RPE65 via production of VLCFAs.
Cellular Location: Endoplasmic reticulum membrane; Multi-pass membrane protein. Tissue Location: Ubiquitous.. The following patways have been known to be associated with this gene. Breast Neoplasms, Congenital Abnormalities, Disease Models, Animal, Fatty Liver, Inflammation, Liver Diseases, Weight Gain are some of the diseases may be linked to ELOVL1 Antibody (N-term) Blocking Peptide. Adipose Tissue, Bladder, Blood, Brain, Connective Tissue, Eye, Liver, Lung, Skin, Thyroid tissues are correlated with this protein.